Selective spectrofluorimetric method for the determination of perindopril erbumine in bulk and tablets through derivatization with dansyl chloride by Amir Sakur et al.
Sakur et al. Journal of Analytical Science and Technology  (2015) 6:12 
DOI 10.1186/s40543-015-0045-6RESEARCH ARTICLE Open AccessSelective spectrofluorimetric method for the
determination of perindopril erbumine in bulk
and tablets through derivatization with dansyl
chloride
Amir Alhaj Sakur1, Tamim Chalati2 and Hanan Fael1*Abstract
Background: Perindopril erbumine is an antihypertensive, which belongs to the category of angiotensin-converting
enzyme inhibitors (ACE inhibitors) that inhibit the conversion of angiotensin I to angiotensin II.
Methods: A new, selective, and sensitive spectrofluorimetric method was developed for the determination of
perindopril erbumine based on the reaction with dansyl chloride in alkaline medium to give a highly fluorescent
derivative which was measured at 496 nm after excitation at 340 nm in dichloromethane. The reaction conditions
were studied and optimized.
Results: Under the optimum conditions, the fluorescence intensity was linear over a concentration range of 1.0 to
21.0 μg/mL (R2 = 0.9997) with a detection limit of 0.242 μg/mL. In order to validate the method, the results were
compared with those obtained by a high performance liquid chromatography method.
Conclusions: The proposed method was successfully applied to the analysis of perindopril erbumine in pure form
and tablets with good precision and accuracy as revealed by t- and F tests. The mechanism of the reaction has also
been discussed.
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Perindopril erbumine (PDE) is the tert-butylamine salt
of perindopril, which is the ethyl ester prodrug of the
angiotensin-converting enzyme (ACE) inhibitor, perindo-
prilat. Perindopril erbumine is chemically described as
2-methylpropan-2-amine (2S,3aS,7aS)-1-[(2S)-2-[[(1S)-
1-(ethoxycarbonyl) butyl] amino] propanoyl]octahydro-
1H-indole-2-carboxylate, Figure 1. Its empirical formula
is C19H32N2O5C4H11N.
Perindopril erbumine belongs to the category of
angiotensin-converting enzyme inhibitors (ACE inhibitors)
that inhibit the conversion of angiotensin I to angiotensin
II. Perindopril erbumine is indicated for the treatment of
hypertension; this effect appears to result primarily from* Correspondence: hananfael@hotmail.com
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Aleppo, Aleppo, Syria
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in any medium, provided the original work is pthe inhibition of circulating and tissue ACE activity thereby
reducing angiotensin II formation and decreasing vasocon-
striction. Perindopril erbumine is also indicated for pa-
tients with congestive heart failure [British National
Formulary BNF 2014].
Literature reported only few analytical methods for the
determination of PDE in its bulk, dosage forms and hu-
man plasma, such as high performance liquid chroma-
tography (Raju and Rao 2011; Zaazaa et al. 2013; Riyaz
et al. 2012; Chaudhary et al. 2010; Jogia et al. 2010;
Joseph et al. 2011; Prajapati et al. 2011a), HPLC-MS
(Jaina et al. 2006 and Nirogi et al. 2006), high perform-
ance thin layer chromatography (Dewani et al. 2011),
and spectrophotometry (Neelam et al. 2012; Rahman
et al. 2012; Prajapati et al. 2011b). However, the chroma-
tographic methods were found to have certain draw-
backs, such as the expensive instrumentation and high
analysis cost. Spectrophotometric methods, on the otherOpen Access article distributed under the terms of the Creative Commons
g/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
Figure 1 Perindopril erbumine structure.
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simple and economic technique. Therefore, it is still sig-
nificant to develop a new, simple and sensitive method
for the determination of perindopril erbumine.
There seems to be no reports on determination of
such important drug, perindopril erbumine, using spec-
trofluorimetry, which shows several advantages such as
high sensitivity, low detection limit, ease of use, and
less time consumption comparing with other analytical
methods.
Dansyl chloride (DNS) is known to react with primary
and secondary amines, phenolic and alcoholic hydroxyl
groups, and carboxylic acid groups (Bartzatt 2003). DNS
has been used as a fluorogenic reagent for the determin-
ation of many pharmaceutical compounds (Aydoğmuş
et al. 2012; Abd El Ghaffar et al. 2011; Abdel Fattah
et al. 2010; Ulu 2011; Karasakal and Ulu 2013).
This paper describes, for the first time, the derivatiza-
tion of PDE with dansyl chloride. The proposed method
is sensitive, accurate, simple, and selective. It was applied
for the determination of PDE in bulk and as well as in
pharmaceutical preparations.Methods
Chemicals and materials
All reagents and solvents were of analytical grade.
Perindopril erbumine (ROLABO outsourcing S.L.,
Spain) stock standard solution of 1.0 mg/mL was pre-
pared in deionized (DI) water. This solution was freshly
prepared at time of study. A series of working stand-
ard solutions were prepared by diluting aliquots of
stock standard solution with DI water. Dansyl chloride
(5-dimethylaminonaphthalene-1-sulphonyl chloride) was
purchased from Merck, Germany. Solution of DNS was
freshly prepared at 1.0 mg/mL in acetonitrile. Bicarbon-
ate buffer (0.1 M) solution was prepared in DI water and
adjusted to pH 9.5 with 0.1 M sodium hydroxide. Bicar-
bonate buffer solution was kept in refrigerator and used
within about 5 days.Perindopril erbumine tablets, Revosyl® (Ibn Alhaytham
Pharma. Industries Co., Syria) and Neomeril® (Oubari
Pharma, Syria) containing 4 and 8 mg, were purchased
from local medical stores.
Instrumentation
Fluorescence spectra and measurements were obtained
using fluorescence spectrophotometer F-2700 (Hitachi,
Japan) equipped with xenon lamp. Excitation and emission
wavelengths were set at 340 and 496 nm, respectively. The
slit widths for excitation and emission monochromators
were fixed at 5 nm. All measurements were performed in
1-cm quartz cell at room temperature.
Chromatographic (HPLC) analysis was performed on
(Agilent 1200 series, Agilent Technologies, Germany) ap-
paratus equipped with UV detector, autosampler, and col-
umn oven. Chromatographic separation was achieved on
C18 column (5 μm, 100 × 4.6 mm).
Derivatization procedure
A 100 μL of PDE working standard solutions equiva-
lent to a final concentration of 1.0 to 21.0 μg/mL was
transferred into a series of 2-mL micro tubes that con-
tain 100 μL of pH 9.5 bicarbonate buffer solution. A
300 μL of dansyl chloride solution was then added,
and solution was mixed vigorously; then, tubes were
kept in dry block heater at 40°C for 30 min. The tubes
were then cooled, and the dansyl derivative was ex-
tracted three times with 1.5 mL of dichloromethane by
a vortex mean. The organic layer was separated after
centrifuging at 5,000 rpm for 1 min to ensure separ-
ation of organic-aqueous layers. The combined dichlo-
romethane extracts were adjusted to 5 mL with the
same solvent. The fluorescence intensity of the result-
ing solution was measured at 496 nm after excitation
at 340 nm against reagent blank that had been treated
similarly.
Determination of stoichiometric relationship
The composition ratio of the derivative product was de-
termined using Job's continuous variation method and
molar ratio method. In Job's method, equimolar solu-
tions (2.26 × 10−3 M) of perindopril erbumine and dansyl
chloride were mixed in which the total moles of reac-
tants were kept at 4.53 × 10−7 moles. The volume of re-
action phase was kept constant at 300 μL; then, steps
were completed as described under the derivatization
procedure. A plot of fluorescence intensities against the
mole fraction of reagent was then constructed.
On the other hand, the molar ratio method was car-
ried out. Increasing volumes of dansyl chloride were
added to a fixed volume of drug solution. The obtained
fluorescence intensities were then plotted against re-
agent molar ratio.
Figure 3 Effect of the pH on the reaction completion of PDE
(20 μg/mL) with DNS.
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Ten individual tablets were weighed and pulverized care-
fully. An accurately weighed amount of the powder
equivalent to 8 mg of PDE was transferred into 25-mL
volumetric flask and dissolved in 20 mL of bicarbonate
buffer. The content of the flask was sonicated for 20 min
then diluted to volume with bicarbonate buffer. Portion
of this solution was centrifuged at 5,000 rpm for 10 min.
Suitable aliquot of the supernatant was then transferred
into micro tubes that contain 100 μL of DI water. A 300
μL of dansyl chloride solution was then added, and pro-
cedure was continued as mentioned above.
Results and discussion
Fluorescence spectra
Perindopril erbumine contains two amino groups and
can therefore react with dansyl chloride in alkaline
medium to give a strongly fluorescent product. On con-
trast, a reagent blank gave a negligible fluorescence sig-
nal at the chosen excitation and emission wavelengths.
Under the described experimental conditions, the excita-
tion spectra was obtained showing two maximum excita-
tion wavelength at 260 and 340 nm, respectively. The
excitation wavelength of 340 was employed, and emis-
sion spectra were obtained showing emission wavelength
maxima at 496 nm (Figure 2).
Optimization of reaction conditions
Effect of pH
Effect of pH on the derivatization reaction was investi-
gated using three different buffers in the alkaline region.
Bicarbonate, phosphate, and borate buffers were studied.
Buffers with amino groups such as tris and triethylamine
were excluded, since they react with DNS reagent. The
reaction was carried out initially at lab temperature for
30 min. The highest fluorescence intensity was obtained









Figure 2 Excitation (black) and emission (blue) spectra of the
PDE-DNS derivative after extraction with dichloromethane
(λex = 340 nm, λem = 496 nm).Following that, in the study of temperature effect, bicar-
bonate and borate buffer were tested to find out which
buffer is more appropriate.
Effect of time and temperature
In this study, the reaction between PDE and dansyl
chloride was performed using pH 9.5 bicarbonate buffer
at different temperatures (20°C, 30°C, 40°C, and 50°C)
for various time intervals (10, 20, 30, 45, and 60 min).
As it is seen in Figure 4, the derivatization reaction was
found to be completed after 30 min at 40°C. Subse-
quently, borate buffer was tested at 40°C for 30 min and
bicarbonate buffer was preferred over it.
Effect of buffer volume and concentration
Under the above described experimental conditions, the
volume required of 0.1 M bicarbonate buffer (pH 9.5)
was tested. As shown in Figure 5, a volume of 100 μL
has given a maximum fluorescence intensity; thus, it was
chosen to proceed the reaction. In addition, the buffer
concentration was investigated at three different molarities
(0.05, 0.1, and 0.2 M). It was found that 0.1 M has given
the best results; thus, it was used for the next experiments.Figure 4 Effect of the temperature and time on the reaction
completion of PDE (20 μg/mL) with DNS.
Figure 5 Effect of the volume added of 0.1 M bicarbonate buffer
at pH 9.5 on the derivatization reaction of PDE (20 μg/mL).
Table 1 The maximum excitation and emission wavelengths
of the PDE-DNS derivatization product and its fluorescence
intensities in different organic extraction solvents
Extraction solvent λex/λem (nm) Fluorescence intensity
a
Sample Blank
Dichloromethane 340/496 540.3 3.6
Chloroform 337/494 432.7 3.5
Diethyl ether 330/489 391.5 3.0
Ethyl acetate 323/459 876.9 636.3
aPDE concentration = 20 μg/mL.
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The influence of the volume of dansyl chloride solution
was examined by addition of different volumes of 0.1%
w/v reagent in the range of 50 to 500 μL (Figure 6). A
maximum and steady fluorescence intensity was ob-
tained when more than 200 μL of dansyl chloride solu-
tion was utilized. Thus, a fixed volume of 300 μL was
used in the optimal procedureEffect of extraction solvent
The aqueous reaction medium contains, in addition to
the derivatization product, a highly fluorescent secondary
product: dansyl hydroxide (Bartzatt 2003). In order to
avoid the interference of this compound, an extraction step
has been performed, so that the polar dansyl hydroxide
remained in the aqueous phase and derivatization product
moved to the immiscible organic solvent. For this purpose,
different solvents including dichloromethane, chloroform,
diethyl ether, and ethyl acetate were tested.
Ethyl acetate was rejected, since the blank value was
very high when it was employed as an extractant. How-
ever, the highest fluorescence was obtained upon using
dichloromethane (Table 1). The emission and excitationFigure 6 Effect of the volume added of 0.1% w/w dansyl
chloride on the derivatization reaction of PDE (20 μg/mL).spectra of derivatization product of perindopril erbu-
mine in dichloromethane are shown in Figure 2.
Stoichiometric relationship of the reaction
Under the described conditions, the stoichiometry of the
reaction between the drug and DNS was studied by Job's
method of continuous variation and molar ratio method.
As shown in Figures 7 and 8, the stoichiometry of the reac-
tion was found to be 2:1 ratio (DNS/drug), confirming that
one molecule of PDE reacts with two molecules of DNS.
Perindopril erbumine contains a secondary amine in the
perindopril moiety and a primary aliphatic amine in the
erbumine molecule. In alkaline medium, these amine
groups become more basic, and thus the electron pairs on
the nitrogen atoms are free and could be involved easily in
nucleophilic reactions. The reaction may be illustrated by
the attack of these nucleophilic groups into the sulfonyl
chloride group of DNS. A schematic proposal of the reac-
tion pathway is given in Scheme 1.
Validation of the proposed method
Linearity
Under the optimum experimental conditions, standard
calibration curve was constructed at eight concentration
levels (n = 5). The correlation coefficient was 0.9997, in-
dicating good linearity over the concentration range of
1.0 to 21.0 μg/mL. The intercept, slope, limit ofFigure 7 Job's plot of continuous variation for the
stoichiometry of reaction between PDE and DNS.
Figure 8 Molar ratio plot for the stoichiometry of reaction
between PDE and DNS.




Linear range (μg/mL) 1.0 to 21.0
Slope 27.164
Standard deviation in the slope 0.178
Intercept 4.5958
Standard deviation in the intercept 1.992
Correlation coefficient 0.9997
Limit of detection (μg/mL) 0.242
Limit of quantification (μg/mL) 0.733
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summarized in Table 2. LOD and LOQ values were cal-
culated according to ICH Q2B using the following
equations:
LOQ ¼ 10 σ=S
LOD ¼ 3:3 σ=S
where σ is the standard deviation of intercept of regres-
sion line and S is the slope of the calibration curve
(Table 2).
Selectivity
The effects of some common excipients used in pharma-
ceutical preparations were studied by analyzing solutions
containing suggested amounts of each excipient. FrequentlyAlkaline me
Scheme 1 Schematic illustration of reaction between PDE and DNS.encountered excipients or additives were studied such as
lactose, microcrystalline cellulose (Avicel), soluble starch,
polyvinylpyrrolidone (PVP k30), talc, and magnesium
stearate. None of the studied excipients has given any
fluorescent product. So, the proposed method is suitable
for analysis of perindopril erbumine in its dosage forms
and application in quality control laboratories.
Precision
The repeatability of proposed method was estimated by
measuring five replicate samples of each concentration
of perindopril erbumine prepared in one laboratory on
the same day. The precision expressed as the relative
standard deviation (RSD%) ranged from 0.61% to 4.92%
for the smallest concentration, indicating good precision
(Table 3).dium
Table 3 Precision and accuracy for determination of PDE
in pure form
Perindopril erbumine (μg/mL) SD RSD% Recovery % t-testb
Taken Founda
1.00 0.976 ± 0.059 0.048 4.92 97.60 1.118
2.20 2.195 ± 0.074 0.060 2.73 99.77 0.186
4.50 4.590 ± 0.104 0.084 1.83 102.00 2.395
6.70 6.733 ± 0.118 0.095 1.41 100.49 0.776
8.70 8.770 ± 0.156 0.126 1.44 100.80 1.242
11.20 11.169 ± 0.125 0.101 0.90 99.72 0.686
16.80 16.940 ± 0.182 0.147 0.86 100.83 2.129
21.00 20.930 ± 0.160 0.129 0.61 99.66 1.213
aAverage of five determination ± confidence limit.
bThe tabulated t-value at 95% confidence limit for 4 degrees of freedom
(n = 5) is 2.78.
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The proposed method was applied on the available com-
mercial tablets that contain PDE, and recoveries are
mentioned in Table 4. However, the method's accuracy
is judged by (1) determining the average amount of PDE
in pure form at several levels and using a significance







As shown in Table 3, the calculated t-value is less than
tabulated t (0.05, 4) value (2.78), and thus there are no
significant differences between the taken and found
concentration at 95% confidence level. Accuracy was
indicated as well by analyzing the recoveries of known dif-
ferent amounts of PDE (Table 3) which varied from 97.60%
to 102.00%. (2) The method's accuracy is also judged by
comparing the results obtained from the presently pro-
posed method with those obtained from a reference
method such as high performance liquid chromatography
(HPLC) (Raju and Rao 2011). The obtained results were
statistically compared with each other (Table 4) usingTable 4 Precision and accuracy for determination of PDE in ta
Tablets Labeled amount of PDE Average PDE
Proposed met
Revosyl 4 mg 4.10 ± 0.036 (10
8 mg 8.34 ± 0.064 (10
Neomeril 4 mg 3.86 ± 0.035 (9
8 mg 7.77 ± 0.075 (9
aAverage and standard deviation of five determinations for the proposed method a
bRecoveries were calculated considering the labeled amount reported by the manu
cThe tabulated t-value at 95% confidence limit for 4 degrees of freedom (n = 5) is 2
freedom for the proposed and reference methods, respectively, is 6.944.







Where XA and XB are PDE mean values in each
pharmaceutical product using the proposed and refer-
ence methods, respectively. S and n are the standard de-
viation and the number of replicate trials conducted on
samples, respectively. With respect to t- and F tests, no
significant differences were found between the calculated
values of both the proposed and the reported methods
at 95% confidence level.
Robustness
Robustness was investigated by evaluating the influence
of minute variations in the experimental conditions such
as volume of reagent (±10 μL), volume of bicarbonate
solution (±5 μL), and reaction time (±5 min). These
minor changes that may happen during the analysis did
not have any significant effect on fluorescence intensity
of the reaction product.
Application to tablets
The proposed method was successfully applied to ana-
lysis of two different commercial tablets (Revosyl® and
Neomeril® tablets) were labeled to contain 4 and 8 mg of
PDE. The mean recovery values were ranged from 96.50
to 104.25, which were identical to the recoveries re-
corded by the reference method (HPLC) as revealed by
t- and F test (Table 4).
Comparison with reported analytical methods
The analytical methods reported in the literature suffered
from one or more disadvantages like poor sensitivity, use
of expensive chemicals, and/or complicated instruments,
as can be seen from Table 5. However, the proposed
method was found to be more sensitive than spectrophoto-
metric and chromatographic methods (except for LC-MS);blets
found (mg/tablet) ± SDa (recovery %)b t- and F testc
hod Reference methodd
2.50) 4.06 ± 0.024 (101.50) 1.734, 2.207
4.25) 8.44 ± 0.040 (105.50) 2.464, 2.612
6.50) 3.90 ± 0.026 (97.50) 1.604, 1.830
7.12) 7.87 ± 0.042 (98.37) 2.299, 3.196
nd three determinations for the reference method.
facturer.
.78 and the tabulated F value at 95% confidence limit for (4, 2) degrees of
Table 5 Performance characteristics of the existing methods used for the determination of PDE
No Method Medium Application Linear range Reference
1 HPLC Phosphate buffer: acetonitrile (65:35) Tablets 20 to 100 μg/mL Raju and Rao 2011
2 HPLC Phosphate buffer: acetonitrile:
Tetrahydrofuran (60:40:0.1)
Tablets (combination with amlodipine) 10 to 100 μg/mL Zaazaa et al. 2013
3 HPLC Phosphate buffer: acetonitrile (55:45) Tablets (combination with amlodipine) 16 to 96 μg/mL Riyaz et al. 2012
4 HPLC Acetonitrile: acidic water (50:50) Tablets (combination with losartan potassium) 1 to 30 μg/mL Chaudhary et al. 2010
5 HPLC Phosphate buffer: acetonitrile (75:25) Dosage forms (combination with indapamide) 24 to 56 μg/mL Jogia et al. 2010
6 HPLC Phosphate buffer: acetonitrile (60:40) Dosage forms (combination with indapamide) 8 to 24 μg/mL Joseph et al. (2011)
7 HPLC Phosphate buffer: acetonitrile (65:35) Tablets (combination with amlodipine) 8 to 60 μg/mL Prajapati et al. 2011a
8 LC-MS/MS - Human plasma 0.5 to 350 ng/mL Jaina et al. 2006
9 LC/MS - Human plasma 0.1 to 100 ng/mL Nirogi et al. [2006]
10 HPTLC Dichloromethane: methanol:
glacial acetic acid (9.5:0.5:0.1)
Dosage forms (combination with indapamide) 1 to 5 μg/band Dewani et al. 2011
11 Spectrophotometry Chloroform Tablets 5 to 125 μg/mL Neelam et al. 2012
12 Spectrophotometry Dimethylsulfoxide Tablets 2.5 to 25 μg/mL Rahman et al. 2012
13 Spectrophotometry Methanol Tablets (combination with amlodipine) 4 to 12 μg/mL Prajapati et al. 2011b
14 Spectrofluorimetry Dichloromethane Tablets 1 to 21 μg/mL This work
Sakur et al. Journal of Analytical Science and Technology  (2015) 6:12 Page 7 of 8in addition to less time-consuming compared with HPLC
methods.
Conclusion
New, simple, and sensitive spectrofluorimetric method for
the determination of PDE has been successfully developed
and validated. The method involved the formation of a
fluorescent derivatization product resulted from the reac-
tion of PDE with DNS in alkaline medium. The proposed
method was specific, precise, and accurate with a compar-
able low detection limit value of 0.242 μg/mL. The method
was effectively applied for determining PDE in pure form
and in tablets without any interference with the excipients.
Therefore, the developed method can be suitable for rou-
tine analysis of PDE in quality control laboratories.
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